Ardent Health Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Ardent Health Inc in the second quarter 2026?
Ardent Health Inc achieved a return on average equity (ROE) of 9.92 % in its second quarter 2026, which is below Ardent Health Inc 's average return on equity, which stands at 17.75%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Healthcare Facilities industry 20 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 825 to 1038.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	5.94 %	10.88 %	10.85 %	17.97 %	-
Y / Y Net Income Change	-63.75 %	-0.81 %	-47.29 %	-97.38 %	42.92 %
Net Income (TTM) in Millions	169	230	230	297	342
Return On Equity (TTM)	9.92 %	13.71 %	14.09 %	18.64 %	22.33 %
ARDT's Total Ranking	# 1038	# 825	# 455	# 629	#
Equity (TTM) in Millions	1,746	1,735	1,686	1,633	1,648
Seq. Equity Change	0.64 %	2.89 %	3.24 %	-0.9 %	5.33 %
Seq. Net Income Change	-40.69 %	-21.24 %	6052.61 %	-98.74 %	62.3 %

Back to ARDT Management Effectiveness >> ARDT's 5 Years Annual ROE >> Compare ARDT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 21
Sector	# 143
Overall	# 1038

Return On Equity Statistics
High	Average	Low
23.33 %	17.75 %	9.92 %
(Dec 31 2024)		(Jun 30 2026)

ARDT Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Equity in Millions	1,686	1,521	0	0	0
Y / Y Equity Change	10.85 %	-	-	-	-
Net Income in Millions	230	300	0	0	0
Y / Y Net Income Change	-23.21 %	-	-	-	-
Return On Equity	13.65 %	19.7 %	-	-	-

Back to ARDT Management Effectiveness >> ARDT's 5 Years Annual ROE >> Compare ARDT ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 13.65 %, due to deterioration of net income.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ARDT's' Return on Equity at Yahoo Finance
ARDT's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ARDT's Competitors
Subscribers only: Roe for Ardent Health Inc 's Suppliers
Subscribers only: Return On Equity for ARDT's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Pacs Group Inc	27.00 %
Sotera Health Company	26.75 %
Insulet Corporation	26.69 %
Bioventus Inc	25.96 %
Johnson and Johnson	25.74 %
Encompass Health Corporation	25.52 %
Resmed Inc	24.21 %
Healthcare Services Group Inc	24.12 %
Electromed Inc	23.65 %
Iradimed Corporation	23.45 %
Vertex Pharmaceuticals Inc	23.31 %
Lantheus Holdings Inc	23.27 %
Msa Safety Inc	23.15 %
Prestige Consumer Healthcare Inc	21.77 %
Jazz Pharmaceuticals Plc	21.37 %
Neurocrine Biosciences Inc	21.13 %
Universal Health Services Inc	20.89 %
Puma Biotechnology Inc	20.85 %
Entera Bio Ltd	20.82 %
United Therapeutics Corporation	20.18 %
Ligand Pharmaceuticals Incorporated	20.06 %
Harmony Biosciences Holdings inc	20.06 %
Pediatrix Medical Group Inc	19.89 %
Theravance Biopharma inc	19.40 %
Krystal Biotech Inc	19.34 %
Ani Pharmaceuticals Inc	19.33 %
Brightspring Health Services Inc	18.93 %
Sbc Medical Group Holdings Incorporated	18.69 %
West Pharmaceutical Services Inc	18.51 %
Intuitive Surgical Inc	17.82 %

Date modified: 2026-08-13T04:05:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.